News from the FDA/CDC
Latest News
Risk of infections low among kids receiving systemic meds for psoriasis, study finds
The analysis included 2,338 patients with psoriasis aged 17 years and younger who started new treatment with ustekinumab, etanercept, or...
News from the FDA/CDC
CDC reports uptick in invasive Strep A infections
Consider this bacterial infection as a possible cause of severe illness in children and adults.
News from the FDA/CDC
FDA approves Idacio as eighth adalimumab biosimilar in U.S.
Data for Idacio (adalimumab-aacf) showed safety, efficacy, and immunogenicity similar to Humira.
News
FDA OKs first fecal transplant therapy for recurrent C. difficile
The application for Rebyota received priority review and had orphan drug and breakthrough therapy designation.
News from the FDA/CDC
FDA approves upadacitinib (Rinvoq) for sixth indication
Upadacitinib’s approval for nonradiographic axial spondyloarthritis marks the sixth indication in the United States for the Janus kinase inhibitor...
News from the FDA/CDC
FDA approves dupilumab for treatment of prurigo nodularis
Approval was based on data from two randomized, controlled trials, PRIME and PRIME2, comparing dupilumab with placebo in 311 adults with...
News from the FDA/CDC
FDA okays spesolimab, first treatment for generalized pustular psoriasis
The drug received priority review and had orphan drug and breakthrough therapy designation.
News from the FDA/CDC
CDC gives final approval to Omicron COVID-19 vaccine boosters
“If you are eligible, there is no bad time to get your COVID-19 booster,” said CDC Director Rochelle Walensky, MD.
News from the FDA/CDC
COVID to blame as U.S. life expectancy falls
The overall drop took national life expectancy from 78.8 years in 2019 to 77 years in 2020.
News from the FDA/CDC
FDA approves adalimumab-bwwd biosimilar (Hadlima) in high-concentration form
The 100-mg/mL version of adalimumab-bwwd (Hadlima) is indicated for the same seven conditions as its 50-mg/mL counterpart.
News from the FDA/CDC
U.S. tops 10,000 confirmed monkeypox cases: CDC
“We are still operating under a containment goal, although I know many states are starting to wonder if we’re shifting to more of a mitigation...